Efficacy and safety of preemptive therapy for cytomegalovirus end-organ disease in people living with HIV: a systematic review and meta-analysis

Anti-cytomegalovirus preemptive therapy to prevent cytomegalovirus disease in HIV-infected patients: a systematic review

(2023) Prenali Dwisthi Sattwika et al.   Infectious Diseases

Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study

(2021) A Albasanz‐Puig et al.   HIV MEDICINE

What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis

(2021) Rachael M Burke et al.   Journal of the International AIDS Society

Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy

(2019) R. Perello et al.   BMC INFECTIOUS DISEASES

Seroprevalencia de citomegalovirus en donantes de órganos y receptores de trasplante renal, Colombia, 2010-2014

(2016) Yazmin Rocío Arias-Murillo et al.   Biomedica

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America

(2016) Brenda Crabtree-Ramírez et al.   PLoS One

Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia

(2014) Sarah Mattioni et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era

(2013) Daisuke Mizushima et al.   PLoS One

Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania

(2012) Arne B. Brantsæter et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

(2009) D. A. Wohl et al.   HIV CLINICAL TRIALS

Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa

(2009) Lara Isobel Compston et al.   JOURNAL OF MEDICAL VIROLOGY

Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy

(2009) Andre C. Kalil et al.   PLoS One